Jump to ContentJump to Main Navigation
Oxford Textbook of Medicine$
Users without a subscription are not able to see the full content.

Edited by David A. Warrell, Timothy M. Cox, John D. Firth

Online access to the Oxford Textbook of Medicine in low and middle income countries is available through the World Health Organization-led HINARI Access to Research in Health programme

Latest update

The May 2013 update sees updates to chapters focusing on Respiratory Medicine and Haematology.

Respiratory Medicine updates include substantial updates to key chapters and new material on a wide range of topics including: new bronchoscopic techniques for early detection of lung cancer, specific causes of effusion and pleural disease, and chronic obstructive pulmonary disease.

Haematology updates include extensive revisions of key chapters on chronic myeloid leukaemia, aplastic anaemia and bone marrow failure disorders, and blood transfusion, with new information on a wide range of matters.

Access token activation

If you have an access token, please click here to activate it.

Sign up for an individual subscription to the Oxford Textbook of Medicine.

Subscriber Login

Forgotten your password?

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Contents

The porphyrias

Chapter:
The porphyrias
Author(s):

T.M. Cox

DOI:
10.1093/med/9780199204854.003.1205

The porphyrias are metabolic disorders characterized by overproduction of haem precursors, principally in the liver and bone marrow. Most porphyrias are inborn errors that affect enzymatic steps in a tightly regulated biosynthetic pathway for haem; nonacute acquired forms also occur.

Hepatic synthesis of haem undergoes rapid and wide oscillations, but haem formation for erythropoiesis is generally constant; it may increase as the erythron expands to meet the demands of blood loss or destruction, or as a consequence of ineffective erythropoiesis.

Acute porphyrias

Clinical presentation—life-threatening neurovisceral attacks occur in four of the porphyrias: acute intermittent porphyria, variegate porphyria, hereditary coproporphyria and Doss porphyria (5-aminolaevulinate dehydratase deficiency). These present with abdominal pain, psychiatric symptoms, signs of sympathetic and hypothalamic autonomic overactivity, sometimes accompanied by convulsions and motor and sensory deficits. They typically develop on exposure to environmental or endogenous factors that place a demand for hepatic haem biosynthesis, the most frequent being changes in reproductive steroid hormones either due to natural hormone cycles or the administration of exogenous gonadal steroids, starvation, intercurrent infection, alcohol and drugs. Acute porphyrias may also be associated with overproduction of photoactive metabolites and thus long-term photosensitivity, which is aggravated during acute attacks.

Diagnosis—this is key to survival of an acute attack of porphyria, which can be suspected on the basis of the past history, in particular of photosensitivity or the intermittent discoloration of urine, and family history, and is confirmed by finding excess water-soluble haem precursors in urine. Enzymatic studies can later be used to verify the exact type of suspected porphyria, with molecular analysis of genes encoding relevant haem synthetic enzymes used to identify at-risk individuals in affected pedigrees.

Management—treatment of an acute porphyric attack mandates immediate withdrawal of inappropriate drugs and other precipitating factors; infusions of haem arginate or other licensed preparations of haem shorten life-threatening episodes and may be effective prophylaxis for recurrent porphyria in women with periodic attacks.

Nonacute porphyrias

The nonacute porphyrias are photosensitivity syndromes caused by excess photoactive macrocyclic porphyrins. The classic manifestations are of severe blistering lesions on sun-exposed skin, particularly of the hands and face, with the formation of vesicles and bullae that may become infected. Healing often leads to cutaneous deformities with loss of digits, scarring of the eyelids, nose, lips, scalp, and occasionally blindness due to corneal scarring. Protoporphyria characteristically causes burning pain and erythema with oedema; blistering is absent. Diagnosis is based on finding excess formed porphyrins in blood and excreta. Sunlight exposure should be avoided as much as possible until the porphyrin abnormality is corrected, e.g. by phlebotomy to cause iron depletion in porphyria cutanea tarda, or by liver or haematopoietic stem-cell transplantation in some (rare) cases.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.